Physician profile
Bridget Darr
NPI 1568803518
$3,072.85
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,443 · 2020: $660 · 2021: $958 · 2022: $12.05.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $869.76 | 2019-2022 | |
| Novo Nordisk INC | $528.15 | 2019-2021 | |
| Glaxosmithkline, LLC. | $287.60 | 2019-2021 | |
| Lilly USA, LLC | $204.37 | 2019-2021 | |
| Amarin Pharma, INC. | $176.11 | 2019-2021 | |
| Pfizer INC. | $132.67 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $125.81 | 2019 | |
| Sanofi-Aventis U.S. LLC | $114.32 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $88.90 | 2019-2021 | |
| Mylan Specialty L.P. | $80.71 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $79.47 | 2020-2021 | |
| Janssen Pharmaceuticals, INC | $69.13 | 2019-2021 | |
| Amgen INC. | $60.99 | 2019-2021 | |
| Abbvie INC. | $53.35 | 2021 | |
| Sanofi Pasteur INC. | $44.44 | 2019-2020 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $31.00 | 2020-2021 | |
| Astellas Pharma US INC | $29.48 | 2020 | |
| Arbor Pharmaceuticals, INC. | $28.68 | 2019 | |
| Dexcom, INC. | $19.40 | 2021 | |
| Ibsa Pharma INC. | $19.38 | 2021 | |
| Genentech USA, INC. | $16.62 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $12.51 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bridget Darr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.